Researchers working on Covid vaccine that people can drink
Darpan News Desk IANS, 23 Jan, 2023 01:58 PM
San Francisco, Jan 23 (IANS) Researchers are working on a Covid-19 vaccine that people may drink instead of receiving with a needle, expanding their focus onto mucosal vaccines, which include nasal vaccines as well as "swish and swallow" oral vaccines.
The vaccine, called QYNDR, completed its phase 1 clinical trial and is currently waiting on more funding to conduct the more detailed, advanced trials that could actually bring the vaccine to market, reports CNET.
"The QYNDR vaccine is pronounced 'kinder', because it's a softer way to deliver a vaccine," Kyle Flanigan, founder of QYNDR's maker, US Specialty Formulations, was quoted as saying.
Moreover, the report said that promising clinical trial results from New Zealand offer hope that QYNDR will be a viable option for protection against the string of Covid-19 variants circulating now.
"It's really challenging to have a vaccine survive making it through your digestive system," Flanigan said.
"We were able to figure out how to get a vaccine past the stomach and into the gut and have it be effective and induce the appropriate response," she added.
Scientists are hopeful that mucosal vaccines will not only protect against severe diseases and death, as revolutionary mRNA vaccines and boosters have but also ward off infections, the report said.
Different from traditional vaccines, mucosal vaccines enter through our mucous membranes, either through our nose (as in the much-discussed nasal Covid-19 vaccine) or through our gut (as in the orally suspended QYNDRs).
Mucosal vaccines have been supported as viable, or even preferable, options for combating Covid-19 infections due to the different types of immunity they produce and the fact that it begins right where the virus enters our bodies, the report mentioned.
Health authorities are warning consumers in Central and Western Canada to avoid eating red onions imported from the U.S. that have been linked to a salmonella outbreak.
A big study to help Medicare officials decide whether to start covering brain scans to check for Alzheimer’s disease missed its goals for curbing health care costs, calling into question whether the pricey tests are worth it.
Canadians living in rural or remote communities are at risk of poorer health outcomes due to a shortage of anesthesia services, say researchers calling for a national strategy to address inequitable access to care.
An experimental blood test was highly accurate at distinguishing people with Alzheimer’s disease from those without it in several studies, boosting hopes that there soon may be a simple way to help diagnose this most common form of dementia.
